To confirm the effect of EFNB2 on CRC LM, we injected sh-NC or sh-EFNB2 SW620 cells into the spleen of nude mice to establish the LM model and found that EFNB2 knockdown reduced the tumor burden of CRC LM (Figs. 1L, S1C). Here, EFNB2 is linked to lymphangioma.